Prosecution Insights
Last updated: April 19, 2026
Application No. 18/487,415

PHYSIOLOGICAL INFORMATION PROCESSING APPARATUS AND PHYSIOLOGICAL INFORMATION PROCESSING METHOD

Non-Final OA §102§103§112
Filed
Oct 16, 2023
Examiner
HOLMES, REX R
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nihon Kohden Corporation
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
2y 12m
To Grant
98%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allow Rate
925 granted / 1153 resolved
+10.2% vs TC avg
Strong +18% interview lift
Without
With
+18.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 12m
Avg Prosecution
40 currently pending
Career history
1193
Total Applications
across all art units

Statute-Specific Performance

§101
5.0%
-35.0% vs TC avg
§103
39.3%
-0.7% vs TC avg
§102
30.1%
-9.9% vs TC avg
§112
15.7%
-24.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1153 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-10 and 12-18 in the reply filed on 2/11/26 is acknowledged. Claim 11 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 2/11/26. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10, 12 and 18 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the processor" in line 4. There is insufficient antecedent basis for this limitation in the claim. Claims 2-10 and 12 are rejected for inheriting the same deficiencies as claim 1. Claim 18 recites the limitation "a computer" in lines 1-2. This is vague as it is unclear if this is the same or different limitation as the “a computer” from claim 13 from which claim 18 depends. Claim 18 recites the limitation "a physiological information processing method" in line 2. This is vague as it is unclear if this is the same or different limitations as the “a physiological information processing method” from claim 13 from which claim 18 depends. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-9 and 12-18 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Inagaki (U.S. Pub. 2016/0220133). Regarding claims 1 and 13, Inagaki discloses a physiological information processing apparatus and method, comprising: one or more processors (e.g. 200; ¶76); and one or more memories configured to store a computer readable instruction (e.g. ¶82), wherein when the computer readable instruction is executed by the processor, the physiological information processing apparatus (e.g. ¶76) is configured to: cause a plurality of physiological sensors to intermittently operate such that an operation time and a standby time are alternately repeated (e.g. S201), obtain a plurality of pieces of physiological information on a patient from the plurality of physiological sensors during the operation time (e.g. S202), and change an operation mode of the plurality of physiological sensors that intermittently operate in accordance with a condition related to at least a part of the plurality of pieces of physiological information or a condition related to at least a part of the plurality of physiological sensors (e.g. see Fig. 8). Regarding claims 2 and 14, Inagaki further discloses wherein the physiological information processing apparatus is configured to: determine whether first physiological information among the plurality of pieces of physiological information satisfies a predetermined condition associated with the first physiological information (e.g. S303), when the first physiological information does not satisfy the predetermined condition, cause the plurality of physiological sensors to stand by during the standby time and after the standby time finished, cause the plurality of physiological sensors to operate (e.g. S304), and when the first physiological information satisfies the predetermined condition, cause the plurality of physiological sensors to operate again without causing the plurality of physiological sensors to stand by (e.g. S301). Regarding claim 3, Inagaki further discloses wherein the first physiological information includes electrocardiogram data, pulse wave data, or body motion data of the patient (e.g. ¶74). Regarding claims 4 and 15, Inagaki further discloses wherein the physiological information processing apparatus is configured to: determine whether first physiological information among the plurality of pieces of physiological information satisfies a predetermined condition associated with the first physiological information (e.g. S202), set the operation time to a first time when the first physiological information does not satisfy the predetermined condition (e.g. S203), and set the operation time to a second time longer than the first time when the first physiological information satisfies the predetermined condition (e.g. S205). Regarding claim 5, Inagaki further discloses wherein the first physiological information includes pulse wave data or electrocardiogram data of the patient (e.g. ¶74). Regarding claims 6 and 16, Inagaki further discloses wherein the physiological information processing apparatus is configured to: calculate a symptom severity score (e.g. “regularity”) indicating a symptom severity of the patient based on the plurality of pieces of physiological information (e.g. S204), determine whether the symptom severity score satisfies a predetermined condition associated with the symptom severity score (e.g. ¶129; “regularity”), set the standby time to a first time when the symptom severity score does not satisfy the predetermined condition (e.g. S205), and set the standby time to a second time shorter than the first time when the symptom severity score satisfies the predetermined condition (e.g. S206). Regarding claims 7 and 17, Inagaki further discloses wherein the physiological information processing apparatus is configured to: determine whether the symptom severity score is larger than a predetermined threshold value (e.g. S204), set the standby time to the first time when the symptom severity score is equal to or less than the predetermined threshold value (e.g. S206), and set the standby time to the second time when the symptom severity score is larger than the predetermined threshold value (e.g. S205). Regarding claim 8, Inagaki further discloses wherein the physiological information processing apparatus is configured to: estimate a symptom severity score to be calculated next based on a currently calculated symptom severity score and at least one previously calculated symptom severity score (e.g. S202), determine whether the estimated symptom severity score is larger than a predetermined threshold value (e.g. S204), set the standby time to the first time when the estimated symptom severity score is equal to or less than the predetermined threshold value (e.g. S206), and set the standby time to the second time when the estimated symptom severity score is larger than the predetermined threshold value (e.g. S205). Regarding claim 9, Inagaki further discloses wherein the physiological information processing apparatus is configured to: determine whether at least a part of the operation time overlaps a predetermined living time period of the patient (e.g. S204), set the standby time to a first time when at least a part of the operation time does not overlap the predetermined living time period (e.g. S206), and set the standby time to a second time longer than the first time when at least a part of the operation time overlaps the predetermined living time period (e.g. S205). Regarding claim 12, Inagaki further discloses wherein the physiological information processing apparatus is attached to the patient (e.g. see Fig. 3), and the physiological information processing apparatus further comprises a wireless communication module configured to wirelessly communicate with an external device (e.g. 250). Regarding claim 18, Inagaki further discloses a non-transitory computer readable storage medium storing a program for causing a computer to execute a physiological information processing method according to claim 13 (e.g. see Fig. 14; ¶76).  Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 10 is/are rejected under 35 U.S.C. 103 as being unpatentable over Inagaki as applied to claims 1-9 and 12-18 above, and further in view of Battista, Jr. (U.S. Pat. 9,380,982 hereinafter “Battista”). Regarding claim 10, Inagaki discloses the claimed invention but fails to explicitly disclose that the device has a sensor removal alarm. However, Battista teaches that it is known to use the physiological signal as set forth in Colum 1, ll. 49-67 to provide a means for discriminating between a disconnected sensor that is removed from the skin and a medical condition to provide for an adaptive alarm that removes false flag alarms and allows for alerting the patient and caregiver to a sensing issue. It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the system as taught by Inagaki, with the sensor disconnected alarm as taught by Battista, since such a modification would provide the predictable results of providing a means for discriminating between a disconnected sensor and a medical condition to provide for an adaptive alarm that removes false flag alarms and allows for alerting the patient and caregiver to a sensing issue. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to REX R HOLMES whose telephone number is (571)272-8827. The examiner can normally be reached Monday-Thursday 7:00AM-5:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at (571) 270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /REX R HOLMES/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Oct 16, 2023
Application Filed
Mar 11, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599771
METHODS AND DEVICES FOR IMPROVED EVOKED RESPONSE DETECTION
2y 5m to grant Granted Apr 14, 2026
Patent 12576277
ADVANCED PACING
2y 5m to grant Granted Mar 17, 2026
Patent 12569693
PORTABLE SINGLE USE AUTOMATED EXTERNAL DEFIBRILLATOR DEVICE
2y 5m to grant Granted Mar 10, 2026
Patent 12569675
ELECTRODE APPARATUS FOR TISSUE STIMULATION AND RELATED METHOD OF USE
2y 5m to grant Granted Mar 10, 2026
Patent 12569688
MEDICAL DEVICE AND METHOD FOR DETECTING ARRHYTHMIA
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
98%
With Interview (+18.3%)
2y 12m
Median Time to Grant
Low
PTA Risk
Based on 1153 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month